Mural Oncology (MURA) Earnings Date & Reports

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MURA is expected to report earnings to fall 30.57% to -134 cents per share on August 19

Mural Oncology MURA Stock Earnings Reports

Q2'25

Est.

$-1.34

Q1'25

Beat

by $0.05

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.09

The last earnings report on May 22 showed earnings per share of -192 cents, beating the estimate of -198 cents. With 18.79K shares outstanding, the current market capitalization sits at 47.49M.

View a ticker or compare two or three

Compare

MURA